PI3K Inhibitors for Cancer Therapy: What has been Achieved So Far?
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
916-930
Author(s):
Peng Wu, Tao Liu and Yongzhou Hu
Spermine Metabolism and Anticancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
118-130
Author(s):
R. Amendola, M. Cervelli, E. Fratini, F. Polticelli, D. E. Sallustio and P. Mariottini
Role of the Akt Pathway in Prostate Cancer
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
163-175
Author(s):
Paul L. de Souza, Pamela J. Russell and John Kearsley
Targeting Myc in Pediatric Malignancies of the Central and Peripheral Nervous System
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
176-188
Author(s):
Michael A. Grotzer, Deborah Castelletti, Giulio Fiaschetti, Tarek Shalaby and Alexandre Arcaro
Nitric Oxide: Cancer Target or Anticancer Agent?
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
214-236
Author(s):
Simone Mocellin
Microdosing, Imaging Biomarkers and SPECT: A Multi-Sided Tripod to Accelerate Drug Development
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
928-934
Author(s):
Ernest K.J. Pauwels, Kim Bergstrom, Giuliano Mariani and Kalevi Kairemo
Cardiovascular Drug Development Using Radiopharmaceuticals
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
935-942
Author(s):
Heikki Ukkonen, Keiichiro Yoshinaga, Jean N. DaSilva, Rob S.B. Beanlands and Juhani Knuuti
Cancer Drug Development with the Help of Radiopharmaceuticals: Academic Experience
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
950-956
Author(s):
Steven M. Larson
Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
957-965
Author(s):
Philip S. Murphy and Mats Bergstrom
Chemokine Receptors as Targets for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
742-757
Author(s):
Xuesong Wu, Vivian C. Lee, Eric Chevalier and Sam T. Hwang